1. Home
  2. PODD
  3. PODD News

Latest Insulet Corporation (PODD) News on December 18, 2024

Why Insulet (PODD) is a Top Momentum Stock for the Long-Term
PODD

Zacks

5 days ago

Why Insulet (PODD) is a Top Momentum Stock for the Long-Term

RMD or PODD: Which Is the Better Value Stock Right Now?
PODD

Zacks

6 days ago

RMD or PODD: Which Is the Better Value Stock Right Now?

PODD

MT Newswires

6 days ago

Nephron Research Adjusts Price Target on Insulet to $310 From $285

PODD

MT Newswires

6 days ago

JPMorgan Raises Insulet Price Target to $330 From $280, Maintains Overweight Rating

Inari Medical Stock Gets RS Rating Upgrade
PODD

Investor's Business Daily

7 days ago

Inari Medical Stock Gets RS Rating Upgrade

PODD

MT Newswires

7 days ago

Wells Fargo Adjusts Price Target on Insulet to $305 From $290, Keeps Overweight Rating

PODD

MT Newswires

7 days ago

Citigroup Raises Price Target on Insulet to $310 From $283, Keeps Buy Rating

PODD

Argus Research

8 days ago

PODD: Raising target price to $289.00

PODD

MT Newswires

8 days ago

Jefferies Adjusts Price Target on Insulet to $340 From $300, Maintains Buy Rating

PODD

MT Newswires

9 days ago

Canaccord Genuity Adjusts Price Target on Insulet to $304 From $269, Keeps Buy Rating

Should You Continue to Retain Insulet Stock in Your Portfolio Now?
PODD

Zacks

9 days ago

Should You Continue to Retain Insulet Stock in Your Portfolio Now?

Insulet awarded $452M in EOFlow patent fight
PODD

MedTech Dive

13 days ago

Insulet awarded $452M in EOFlow patent fight

Insulet Successfully Defends its Intellectual Property Against EOFlow Co. in U.S. District Court
PODD

Business Wire

14 days ago

Insulet Successfully Defends its Intellectual Property Against EOFlow Co. in U.S. District Court

PODD

Argus Research

15 days ago

PODD: Raising target price to $283.00

Novocure Stock Earns 96 RS Rating
PODD

Investor's Business Daily

15 days ago

Novocure Stock Earns 96 RS Rating

Here's Why Insulet (PODD) is a Strong Growth Stock
PODD

Zacks

19 days ago

Here's Why Insulet (PODD) is a Strong Growth Stock

If You Invested $1000 in Insulet a Decade Ago, This is How Much It'd Be Worth Now
PODD

Zacks

22 days ago

If You Invested $1000 in Insulet a Decade Ago, This is How Much It'd Be Worth Now

PODD Stock to Gain From Launch of Omnipod 5 With Abbott's CGM in US
PODD

Zacks

a month ago

PODD Stock to Gain From Launch of Omnipod 5 With Abbott's CGM in US

Insulet adds Abbott’s FreeStyle Libre 2 Plus to Omnipod 5’s compatibility roster
PODD

Medical Device Network

a month ago

Insulet adds Abbott’s FreeStyle Libre 2 Plus to Omnipod 5’s compatibility roster

Insulet Announces Omnipod® 5 System is Now Compatible with Abbott’s FreeStyle Libre 2 Plus Sensor in the U.S.
PODD

Business Wire

a month ago

Insulet Announces Omnipod® 5 System is Now Compatible with Abbott’s FreeStyle Libre 2 Plus Sensor in the U.S.

PODD

MT Newswires

a month ago

Baptista Downgrades Insulet to Underperform

Insulet's (NASDAQ:PODD) Solid Profits Have Weak Fundamentals
PODD

Simply Wall St.

a month ago

Insulet's (NASDAQ:PODD) Solid Profits Have Weak Fundamentals

Insulet to Present at Upcoming Investor Conferences
PODD

Business Wire

a month ago

Insulet to Present at Upcoming Investor Conferences

Are You a Momentum Investor? This 1 Stock Could Be the Perfect Pick
PODD

Zacks

a month ago

Are You a Momentum Investor? This 1 Stock Could Be the Perfect Pick

Zacks.com featured highlights include NVIDIA, Insulet and Howmet Aerospace
PODD

Zacks

a month ago

Zacks.com featured highlights include NVIDIA, Insulet and Howmet Aerospace

PODD

Argus Research

a month ago

PODD: Raising target price to $289.00

Buy Profitable S&P 500 Stocks as the Index Tops 6000: NVIDIA & 2 More
PODD

Zacks

a month ago

Buy Profitable S&P 500 Stocks as the Index Tops 6000: NVIDIA & 2 More

Why Insulet (PODD) is a Top Growth Stock for the Long-Term
PODD

Zacks

a month ago

Why Insulet (PODD) is a Top Growth Stock for the Long-Term

PODD Stock Gains on Q3 Earnings and Revenue Beat, '24 Sales View Up
PODD

Zacks

a month ago

PODD Stock Gains on Q3 Earnings and Revenue Beat, '24 Sales View Up

Insulet price target raised to $317 from $234 at Morgan Stanley
PODD

TipRanks

a month ago

Insulet price target raised to $317 from $234 at Morgan Stanley

PODD

MT Newswires

a month ago

Barclays Adjusts Price Target on Insulet to $234 From $220, Maintains Equalweight Rating

Results: Insulet Corporation Beat Earnings Expectations And Analysts Now Have New Forecasts
PODD

Simply Wall St.

a month ago

Results: Insulet Corporation Beat Earnings Expectations And Analysts Now Have New Forecasts

Insulet Third Quarter 2024 Earnings: Beats Expectations
PODD

Simply Wall St.

a month ago

Insulet Third Quarter 2024 Earnings: Beats Expectations

S&P 500 Gains and Losses Today: Axon Shares Surge as Taser Maker Tops Estimates
PODD

Investopedia

a month ago

S&P 500 Gains and Losses Today: Axon Shares Surge as Taser Maker Tops Estimates

Insulet Soars Out Of Buy Zone As 'Beat-And-Raise Cadence' Continues
PODD

Investor's Business Daily

a month ago

Insulet Soars Out Of Buy Zone As 'Beat-And-Raise Cadence' Continues

Costco Stock Breaks Out Past Buy Point, Reaches All-Time High
PODD

Investor's Business Daily

a month ago

Costco Stock Breaks Out Past Buy Point, Reaches All-Time High

PODD

MT Newswires

a month ago

Wolfe Research Adjusts Price Target on Insulet to $265 From $220

PODD

MT Newswires

a month ago

Leerink Partners Adjusts Price Target on Insulet to $278 From $262

PODD

MT Newswires

a month ago

Jefferies Raises Price Target on Insulet to $300 From $260

PODD

MT Newswires

a month ago

BTIG Raises Price Target on Insulet to $270 From $260

PODD

MT Newswires

a month ago

Bernstein Adjusts Price Target on Insulet to $305 From $300

PODD

MT Newswires

a month ago

Stifel Adjusts Price Target on Insulet to $245 From $185

Insulet Corp (PODD) Q3 2024 Earnings Call Highlights: Record Revenue Growth and Strategic Expansions
PODD

GuruFocus.com

a month ago

Insulet Corp (PODD) Q3 2024 Earnings Call Highlights: Record Revenue Growth and Strategic Expansions

Insulet (PODD) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates
PODD

Zacks

a month ago

Insulet (PODD) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates

Insulet (PODD) Q3 Earnings and Revenues Top Estimates
PODD

Zacks

a month ago

Insulet (PODD) Q3 Earnings and Revenues Top Estimates

PODD

MT Newswires

a month ago

Insulet Q3 Adjusted Earnings, Revenue Rise, 2024 Revenue Outlook Raised

PODD

Associated Press Finance

a month ago

Insulet: Q3 Earnings Snapshot

Insulet Reports Third Quarter 2024 Revenue Increase of 26% Year-Over-Year (25% Constant Currency1)
PODD

Business Wire

a month ago

Insulet Reports Third Quarter 2024 Revenue Increase of 26% Year-Over-Year (25% Constant Currency1)

PODD

MT Newswires

a month ago

Bernstein Starts Insulet With Outperform Rating, $300 Price Target

PODD

Argus Research

a month ago

PODD: Raising target price to $253.00

Insulet Stock Gains From Expansion Strategies, Innovation
PODD

Zacks

a month ago

Insulet Stock Gains From Expansion Strategies, Innovation

Stay Ahead of the Game With Insulet (PODD) Q3 Earnings: Wall Street's Insights on Key Metrics
PODD

Zacks

a month ago

Stay Ahead of the Game With Insulet (PODD) Q3 Earnings: Wall Street's Insights on Key Metrics

Insulet Announces Array of Activities to Support National Diabetes Awareness Month and World Diabetes Day in November
PODD

Business Wire

2 months ago

Insulet Announces Array of Activities to Support National Diabetes Awareness Month and World Diabetes Day in November

Insulet (PODD) Earnings Expected to Grow: Should You Buy?
PODD

Zacks

2 months ago

Insulet (PODD) Earnings Expected to Grow: Should You Buy?

Insulet rolls out iPhone app for Omnipod 5 insulin pump in US
PODD

Medical Device Network

2 months ago

Insulet rolls out iPhone app for Omnipod 5 insulin pump in US

Omnipod® 5 App for iPhone® Now Fully Available in the United States
PODD

Business Wire

2 months ago

Omnipod® 5 App for iPhone® Now Fully Available in the United States

Here Is Why Analysts See More Growth After Meta's Impressive Gains
PODD

Investor's Business Daily

2 months ago

Here Is Why Analysts See More Growth After Meta's Impressive Gains

Is Insulet Stock a Smart Addition to Your Portfolio Right Now?
PODD

Zacks

2 months ago

Is Insulet Stock a Smart Addition to Your Portfolio Right Now?

PAHC vs. PODD: Which Stock Is the Better Value Option?
PODD

Zacks

2 months ago

PAHC vs. PODD: Which Stock Is the Better Value Option?

Profitable S&P 500 Stocks to Buy in a Strong Q4: NVIDIA & 2 Others
PODD

Zacks

2 months ago

Profitable S&P 500 Stocks to Buy in a Strong Q4: NVIDIA & 2 Others

Solventum Stock Earns 81 RS Rating
PODD

Investor's Business Daily

2 months ago

Solventum Stock Earns 81 RS Rating

PODD

MT Newswires

2 months ago

Leerink Adjusts Price Target on Insulet to $262 From $240

Insulet price target raised to $260 from $250 at BTIG
PODD

TipRanks

2 months ago

Insulet price target raised to $260 from $250 at BTIG

PODD

MT Newswires

2 months ago

BTIG Adjusts Price Target on Insulet to $260 From $250

Is Insulet Corporation (NASDAQ:PODD) The Top Stock With Improving Technical Ratings According To Piper Sandler?
PODD

Insider Monkey

2 months ago

Is Insulet Corporation (NASDAQ:PODD) The Top Stock With Improving Technical Ratings According To Piper Sandler?

We Like These Underlying Return On Capital Trends At Insulet (NASDAQ:PODD)
PODD

Simply Wall St.

2 months ago

We Like These Underlying Return On Capital Trends At Insulet (NASDAQ:PODD)

National Campaign Launches to Combat Diabetes Stigma Using Comedy
PODD

PR Newswire

2 months ago

National Campaign Launches to Combat Diabetes Stigma Using Comedy

Insulet Corp (PODD) Q2 2024 Earnings Call Highlights: Strong Revenue Growth and Raised Guidance
PODD

GuruFocus.com

2 months ago

Insulet Corp (PODD) Q2 2024 Earnings Call Highlights: Strong Revenue Growth and Raised Guidance

PODD

MT Newswires

2 months ago

Baird Adjusts Price Target on Insulet to $280 From $238, Maintains Outperform Rating

Here’s Why ClearBridge Growth Strategy Increased its Position in Insulet Corporation (PODD)
PODD

Insider Monkey

2 months ago

Here’s Why ClearBridge Growth Strategy Increased its Position in Insulet Corporation (PODD)

PODD

Argus Research

2 months ago

PODD: Lowering target price to $185.00

FMR LLC Bolsters Position in Insulet Corp with Strategic Share Acquisition
PODD

GuruFocus.com

2 months ago

FMR LLC Bolsters Position in Insulet Corp with Strategic Share Acquisition

HLN or PODD: Which Is the Better Value Stock Right Now?
PODD

Zacks

3 months ago

HLN or PODD: Which Is the Better Value Stock Right Now?

PODD

MT Newswires

3 months ago

Citigroup Adjusts Price Target on Insulet to $275 From $250, Maintains Buy Rating

Fidelity Growth Strategies Fund Trimmed Insulet Corporation (PODD) to Manage the Position Size
PODD

Insider Monkey

3 months ago

Fidelity Growth Strategies Fund Trimmed Insulet Corporation (PODD) to Manage the Position Size

Insulet to Announce Third Quarter 2024 Financial Results on November 7, 2024
PODD

Business Wire

3 months ago

Insulet to Announce Third Quarter 2024 Financial Results on November 7, 2024

Insulet's (NASDAQ:PODD) investors will be pleased with their respectable 48% return over the last five years
PODD

Simply Wall St.

3 months ago

Insulet's (NASDAQ:PODD) investors will be pleased with their respectable 48% return over the last five years

PODD

MT Newswires

3 months ago

Canaccord Genuity Adjusts Insulet Price Target to $269 From $236, Maintains Buy Rating

PODD

MT Newswires

3 months ago

Piper Sandler Adjusts Price Target on Insulet to $285 From $230, Maintains Overweight Rating

BAX vs. PODD: Which Stock Should Value Investors Buy Now?
PODD

Zacks

3 months ago

BAX vs. PODD: Which Stock Should Value Investors Buy Now?

A Look At The Intrinsic Value Of Insulet Corporation (NASDAQ:PODD)
PODD

Simply Wall St.

3 months ago

A Look At The Intrinsic Value Of Insulet Corporation (NASDAQ:PODD)

PODD

MT Newswires

3 months ago

Insulet Insider Sold Shares Worth $1,718,283, According to a Recent SEC Filing

Insider Sale: Director Timothy Scannell Sells 5,000 Shares of Insulet Corp (PODD)
PODD

GuruFocus.com

3 months ago

Insider Sale: Director Timothy Scannell Sells 5,000 Shares of Insulet Corp (PODD)

PODD

MT Newswires

3 months ago

Insulet Insider Sold Shares Worth $1,129,200, According to a Recent SEC Filing

Insulet’s (PODD) Sales And Margins Surpassed Expectations
PODD

Insider Monkey

3 months ago

Insulet’s (PODD) Sales And Margins Surpassed Expectations

PODD

Morningstar Research

3 months ago

Analyst Report: Insulet Corporation

Should You Continue to Retain PODD Stock in Your Portfolio Now?
PODD

Zacks

3 months ago

Should You Continue to Retain PODD Stock in Your Portfolio Now?

PODD

Morningstar Research

4 months ago

Analyst Report: Insulet Corporation

Here's Why We Think Insulet (NASDAQ:PODD) Is Well Worth Watching
PODD

Simply Wall St.

4 months ago

Here's Why We Think Insulet (NASDAQ:PODD) Is Well Worth Watching

Why Insulet Stock Was Zooming Higher This Week
PODD

Motley Fool

4 months ago

Why Insulet Stock Was Zooming Higher This Week

Insider Sale at Insulet Corp (PODD): SVP & Chief Technology Officer Mark Field Sells Shares
PODD

GuruFocus.com

4 months ago

Insider Sale at Insulet Corp (PODD): SVP & Chief Technology Officer Mark Field Sells Shares

PODD

Argus Research

4 months ago

PODD: Raising target price to $202.00

S&P 500 Gains and Losses Today: Medical Device Makers ResMed, Insulet Lead Index
PODD

Investopedia

4 months ago

S&P 500 Gains and Losses Today: Medical Device Makers ResMed, Insulet Lead Index

PODD

MT Newswires

4 months ago

Sector Update: Health Care Stocks Edge Higher in Late Afternoon

PODD

MT Newswires

4 months ago

Sector Update: Health Care Stocks Mixed Tuesday Afternoon

Top Stock Movers Now: Nvidia, Insulet, Paramount Global, and More
PODD

Investopedia

4 months ago

Top Stock Movers Now: Nvidia, Insulet, Paramount Global, and More

This Healthcare Stock Is the Best Performer in the S&P 500 After FDA Approval
PODD

Barrons.com

4 months ago

This Healthcare Stock Is the Best Performer in the S&P 500 After FDA Approval

Insulet's Omnipod 5 Wins FDA Approval for Type 2 Diabetes
PODD

Zacks

4 months ago

Insulet's Omnipod 5 Wins FDA Approval for Type 2 Diabetes

Insulet’s Trang Ly on overcoming ‘clinical inertia’ in diabetes care
PODD

MedTech Dive

4 months ago

Insulet’s Trang Ly on overcoming ‘clinical inertia’ in diabetes care

Insulet Omnipod cleared by FDA for type 2 diabetes
PODD

Medical Device Network

4 months ago

Insulet Omnipod cleared by FDA for type 2 diabetes

Share on Social Networks: